148 related articles for article (PubMed ID: 17976271)
1. Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics.
Date AA; Nagarsenker MS
J Pharm Pharmacol; 2007 Nov; 59(11):1583-4. PubMed ID: 17976271
[No Abstract] [Full Text] [Related]
2. Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS).
Kadu PJ; Kushare SS; Thacker DD; Gattani SG
Pharm Dev Technol; 2011 Feb; 16(1):65-74. PubMed ID: 20088679
[TBL] [Abstract][Full Text] [Related]
3. [Preparation and evaluation of self-microemulsifying drug delivery systems containing atorvastatin].
Shen HR; Li ZD; Zhong MK
Yao Xue Xue Bao; 2005 Nov; 40(11):982-7. PubMed ID: 16499080
[TBL] [Abstract][Full Text] [Related]
4. Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase.
Whitfield LR; Stern RH; Sedman AJ; Abel R; Gibson DM
Eur J Drug Metab Pharmacokinet; 2000; 25(2):97-101. PubMed ID: 11112089
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of atorvastatin.
Lennernäs H
Clin Pharmacokinet; 2003; 42(13):1141-60. PubMed ID: 14531725
[TBL] [Abstract][Full Text] [Related]
6. HPLC assay and pharmacokinetic study of atorvastatin in beagle dogs after oral administration of atorvastatin self-microemulsifying drug delivery system.
Shen HR; Li ZD; Zhong MK
Pharmazie; 2006 Jan; 61(1):18-20. PubMed ID: 16454200
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.
Shen H; Zhong M
J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176
[TBL] [Abstract][Full Text] [Related]
8. Statins as potential antimalarial drugs: low relative potency and lack of synergy with conventional antimalarial drugs.
Wong RP; Davis TM
Antimicrob Agents Chemother; 2009 May; 53(5):2212-4. PubMed ID: 19258270
[TBL] [Abstract][Full Text] [Related]
9. Incomparable effectiveness--apples to apples?
Winter FD; Wheelan KR
Mayo Clin Proc; 2010 Aug; 85(8):764; author reply 764-6. PubMed ID: 20675515
[No Abstract] [Full Text] [Related]
10. Atorvastatin: safety and tolerability.
Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
Expert Opin Drug Saf; 2010 Jul; 9(4):667-74. PubMed ID: 20553090
[TBL] [Abstract][Full Text] [Related]
11. [In addition to atorvastatin. Innovative antibody lowers LDL around 72%].
Einecke D
MMW Fortschr Med; 2012 Apr; 154(7):28. PubMed ID: 22558865
[No Abstract] [Full Text] [Related]
12. Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia.
Stulc T; Vrablík M; Kasalová Z; Ceska R; Marinov I
Atherosclerosis; 2003 Jan; 166(1):197-8. PubMed ID: 12482568
[No Abstract] [Full Text] [Related]
13. PCSK9 inhibition: the next statin?
Vogel RA
J Am Coll Cardiol; 2012 Jun; 59(25):2354-5. PubMed ID: 22465426
[No Abstract] [Full Text] [Related]
14. Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench.
Shimada K; Miyauchi K; Daida H
Circulation; 2004 May; 109(18):e213-4; author reply e213-4. PubMed ID: 15136515
[No Abstract] [Full Text] [Related]
15. Is rosuvastatin really a more efficient therapeutic option than atorvastatin?
Soto J; Fernandez de Bobadilla J
Value Health; 2006; 9(4):276-7; author reply 277-9. PubMed ID: 16903999
[No Abstract] [Full Text] [Related]
16. Coadministration of dabigatran etexilate and atorvastatin: assessment of potential impact on pharmacokinetics and pharmacodynamics.
Stangier J; Rathgen K; Stähle H; Reseski K; Körnicke T; Roth W
Am J Cardiovasc Drugs; 2009; 9(1):59-68. PubMed ID: 19178132
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin treatment and vaccination efficacy.
Packard RR; Schlegel S; Senouf D; Burger F; Sigaud P; Perneger T; Siegrist CA; Mach F
J Clin Pharmacol; 2007 Aug; 47(8):1022-7. PubMed ID: 17548534
[No Abstract] [Full Text] [Related]
18. Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia.
Meena AK; Ratnam DV; Chandraiah G; Ankola DD; Rao PR; Kumar MN
Lipids; 2008 Mar; 43(3):231-41. PubMed ID: 18196308
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin (Lipitor).
Tucker G
Conn Med; 1998 May; 62(5):283-5. PubMed ID: 9639958
[No Abstract] [Full Text] [Related]
20. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
Wamhoff BR; Dixon JL; Sturek M
J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
